Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001398344-25-009407
Filing Date
2025-05-14
Accepted
2025-05-14 16:05:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10204
2 fp0093506-15_ex991.htm EX-99.1 6047
  Complete submission text file 0001398344-25-009407.txt   18181
Mailing Address 1245 Q STREET LINCOLN NE 68508
Business Address 1245 Q STREET LINCOLN NE 68508 4024752525
NATIONAL RESEARCH CORP (Subject) CIK: 0000070487 (see all company filings)

EIN.: 470634000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-52417 | Film No.: 25945296
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 2000 AVENUE OF THE STARS, SUITE 1110 LOS ANGELES CA 90067
Business Address 2000 AVENUE OF THE STARS, SUITE 1110 LOS ANGELES CA 90067 3105562721
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (Filed by) CIK: 0001021223 (see all company filings)

EIN.: 954575414 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A